|By PR Newswire||
|March 6, 2014 10:00 AM EST||
NEW YORK, March 6, 2014 /PRNewswire/ -- Valeant Pharmaceuticals North America, LLC, today announced it has donated $250,000 to the National Coalition Against Domestic Violence (NCADV). The donation is a reflection of Valeant's ongoing support and commitment to the wellbeing of women, and is the first of four checks the company will present to NCADV in a one year period for a combined donation goal of $1 million.
"NCADV is thrilled to be working with Valeant as a partner in our efforts to end violence in the home," said Rita Smith, Executive Director of NCADV. "Corporations have the ability to increase the awareness of resources and information about domestic violence to a much larger audience than we can alone, and as a result, together we can make a difference in so many more lives of people who are struggling to get free from the violence."
According to the Bureau of Justice Statistics, 85 percent of domestic violence victims are women, and 1 in 4 women report experiencing domestic violence in their lifetimes. Because Valeant's most important objective is to serve its stakeholders, the majority of which are women, the decision to support a cause like NCADV's came easily.
"Valeant's partnership with the NCADV provides us a tremendous opportunity to make a difference in the lives of those impacted by domestic violence," said Ryan Weldon, Executive Vice President for Valeant Pharmaceuticals. "We make these efforts on behalf of our employees and the consumers and healthcare professionals that support this cause by using our products. We hope this collaboration will continue to grow and enable the NCADV in its mission to end domestic violence."
Valeant partnered with NCADV in October 2013. To date, the partnership has helped 19,000 women by supporting NCADV in:
- Expanding relationships with associations that provide services to victims of violence
- Developing partnerships in the creation of information and materials addressing specific health issues and intimate partner violence
- Expanding topics of health and wellness materials for victims and survivors of domestic violence
- Creating training materials for service providers on how to best serve survivors struggling with health and wellness issues
To learn more about how Valeant is taking a stand against domestic violence and to contribute to the cause, visit enddomesticviolence.valeant.com.
About Valeant Pharmaceuticals North America LLC
Valeant Pharmaceuticals North America LLC, is a specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology, eye health and branded generics. More information about Valeant Pharmaceuticals can be found at www.valeant.com.
About National Coalition Against Domestic Violence
The survivor-led and survivor-focused National Coalition Against Domestic Violence (NCADV) has worked for more than thirty-five years to end violence against women by raising awareness and educating the public about the effects of domestic abuse. Our work includes developing and sustaining ground-breaking public policy at the national level aimed at ending violence; assisting the 2,000+ urban and rural shelters and programs at the local, state, and regional levels of the nation in the programming they offer to victims seeking safety and assistance; and offering programming that empowers and supports the long-term health and safety of victims of domestic violence. Currently, our constituency encompasses more than 70,000 programs, survivors, advocates, and allied individuals and is growing daily. Learn more about us at: www.ncadv.org.
Except as otherwise indicated, all product names, slogans and other marks are trademarks of the Valeant family of companies. DM/OBG/13/0002o
SOURCE Valeant Pharmaceuticals North America, LLC
Sep. 26, 2016 11:30 AM EDT Reads: 983
Sep. 26, 2016 11:30 AM EDT Reads: 2,548
Sep. 26, 2016 11:30 AM EDT Reads: 1,940
Sep. 26, 2016 11:30 AM EDT Reads: 2,528
Sep. 26, 2016 11:15 AM EDT Reads: 2,858
Sep. 26, 2016 11:15 AM EDT Reads: 1,727
Sep. 26, 2016 11:06 AM EDT
Sep. 26, 2016 11:00 AM EDT Reads: 984
Sep. 26, 2016 11:00 AM EDT Reads: 3,715
Sep. 26, 2016 10:45 AM EDT Reads: 2,588
Sep. 26, 2016 10:45 AM EDT Reads: 3,405
Sep. 26, 2016 10:45 AM EDT Reads: 2,225
Sep. 26, 2016 10:45 AM EDT Reads: 3,218
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Sep. 26, 2016 10:30 AM EDT Reads: 890
DevOps at Cloud Expo – being held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real results. Am...
Sep. 26, 2016 10:30 AM EDT Reads: 4,433